Research update for articles published in EJCI in 2012

R P. Dullaart; N.M. Al-Daghri; M. Ashina; A. Bouzas-Mosquera; N.D. Brunetti; C. Buechler; H.S. Chen; J.J. Corrales; M. D'Archivio; A.D. Cas; G.G. Pino; S.A. Gomez-Abril; D. Gyori; H. Haslacher; C. Herder; M.N. Kerstens; M. Koutsilieris; G. Lupattelli; A. Mocsai; P. Msaouel; A. Orfao; P. Ormazabal; R. Pacher; T. Perkmann; J. Peteiro; M. Plischcke; N.L. Reynaert; M.A. Ricci; N.R. Robles; M. Rocha; E.P. Rutten; S. Sabico; F. Santamaria; F. Santoro; A. Schmid; M. Schmidt; H.W. Schytz; K.G. Shyu; H. Tada; B. Thorand; G. Valerio; D.L. Vesely; T.E. Wu; M. Yamagishi; Y.T. Yeh

doi:10.1111/eci.12319

Research update for articles published in EJCI in 2012

R P. Dullaart, N.M. Al-Daghri, M. Ashina, A. Bouzas-Mosquera, N.D. Brunetti, C. Buechler, H.S. Chen, J.J. Corrales, M. D'Archivio, A.D. Cas, G.G. Pino, S.A. Gomez-Abril, D. Gyori, H. Haslacher, C. Herder, M.N. Kerstens, M. Koutsilieris, G. Lupattelli, A. Mocsai, P. MsaouelA. Orfao, P. Ormazabal, R. Pacher, T. Perkmann, J. Peteiro, M. Plischcke, N.L. Reynaert, M.A. Ricci, N.R. Robles, M. Rocha, E.P. Rutten, S. Sabico, F. Santamaria, F. Santoro, A. Schmid, M. Schmidt, H.W. Schytz, K.G. Shyu, H. Tada, B. Thorand, G. Valerio, D.L. Vesely, T.E. Wu, M. Yamagishi, Y.T. Yeh

Pulmonologie

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Phospholipase Cgamma2 (PLCgamma2) is a critical regulator of osteoclast differentiation and basal bone resorption, which was demonstrated by Kertesz et al. in agreement with previous reports(1). The role of the PLCgamma isoenzyme in bone resorption and in adhesion receptor signalling of osteoclasts was further emphasized in a recent review(2) reinforcing the statements made by Kertesz et al.,(1). Moreover, Dr. Faccio's group provided genetic evidence that targeting PLCgamma2 can suppress inflammatory osteolysis(3). This article is protected by copyright. All rights reserved.

Original language	English
Pages (from-to)	1010-1023
Number of pages	14
Journal	European Journal of Clinical Investigation
Volume	44
Issue number	10
DOIs	https://doi.org/10.1111/eci.12319
Publication status	Published - Oct 2014

Keywords

CORONARY-ARTERY-DISEASE
AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA
NEAR-INFRARED SPECTROSCOPY
LOW-FREQUENCY OSCILLATIONS
ISCHEMIC-HEART-DISEASE
SMOOTH-MUSCLE-CELLS
OXIDATIVE STRESS
METABOLIC SYNDROME
ADIPOSE-TISSUE
SOLUBLE CD163

Access to Document

10.1111/eci.12319

Cite this

Dullaart, R. P., Al-Daghri, N. M., Ashina, M., Bouzas-Mosquera, A., Brunetti, N. D., Buechler, C., Chen, H. S., Corrales, J. J., D'Archivio, M., Cas, A. D., Pino, G. G., Gomez-Abril, S. A., Gyori, D., Haslacher, H., Herder, C., Kerstens, M. N., Koutsilieris, M., Lupattelli, G., Mocsai, A., ... Yeh, Y. T. (2014). Research update for articles published in EJCI in 2012. European Journal of Clinical Investigation, 44(10), 1010-1023. https://doi.org/10.1111/eci.12319

@article{47fb82c7fe724d0a92da1172b8cddeae,

title = "Research update for articles published in EJCI in 2012",

abstract = "Phospholipase Cgamma2 (PLCgamma2) is a critical regulator of osteoclast differentiation and basal bone resorption, which was demonstrated by Kertesz et al. in agreement with previous reports(1). The role of the PLCgamma isoenzyme in bone resorption and in adhesion receptor signalling of osteoclasts was further emphasized in a recent review(2) reinforcing the statements made by Kertesz et al.,(1). Moreover, Dr. Faccio's group provided genetic evidence that targeting PLCgamma2 can suppress inflammatory osteolysis(3). This article is protected by copyright. All rights reserved.",

keywords = "CORONARY-ARTERY-DISEASE, AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA, NEAR-INFRARED SPECTROSCOPY, LOW-FREQUENCY OSCILLATIONS, ISCHEMIC-HEART-DISEASE, SMOOTH-MUSCLE-CELLS, OXIDATIVE STRESS, METABOLIC SYNDROME, ADIPOSE-TISSUE, SOLUBLE CD163",

author = "Dullaart, {R P.} and N.M. Al-Daghri and M. Ashina and A. Bouzas-Mosquera and N.D. Brunetti and C. Buechler and H.S. Chen and J.J. Corrales and M. D'Archivio and A.D. Cas and G.G. Pino and S.A. Gomez-Abril and D. Gyori and H. Haslacher and C. Herder and M.N. Kerstens and M. Koutsilieris and G. Lupattelli and A. Mocsai and P. Msaouel and A. Orfao and P. Ormazabal and R. Pacher and T. Perkmann and J. Peteiro and M. Plischcke and N.L. Reynaert and M.A. Ricci and N.R. Robles and M. Rocha and E.P. Rutten and S. Sabico and F. Santamaria and F. Santoro and A. Schmid and M. Schmidt and H.W. Schytz and K.G. Shyu and H. Tada and B. Thorand and G. Valerio and D.L. Vesely and T.E. Wu and M. Yamagishi and Y.T. Yeh",

year = "2014",

month = oct,

doi = "10.1111/eci.12319",

language = "English",

volume = "44",

pages = "1010--1023",

journal = "European Journal of Clinical Investigation",

issn = "0014-2972",

publisher = "Wiley",

number = "10",

}

Dullaart, RP, Al-Daghri, NM, Ashina, M, Bouzas-Mosquera, A, Brunetti, ND, Buechler, C, Chen, HS, Corrales, JJ, D'Archivio, M, Cas, AD, Pino, GG, Gomez-Abril, SA, Gyori, D, Haslacher, H, Herder, C, Kerstens, MN, Koutsilieris, M, Lupattelli, G, Mocsai, A, Msaouel, P, Orfao, A, Ormazabal, P, Pacher, R, Perkmann, T, Peteiro, J, Plischcke, M, Reynaert, NL, Ricci, MA, Robles, NR, Rocha, M, Rutten, EP, Sabico, S, Santamaria, F, Santoro, F, Schmid, A, Schmidt, M, Schytz, HW, Shyu, KG, Tada, H, Thorand, B, Valerio, G, Vesely, DL, Wu, TE, Yamagishi, M & Yeh, YT 2014, 'Research update for articles published in EJCI in 2012', European Journal of Clinical Investigation, vol. 44, no. 10, pp. 1010-1023. https://doi.org/10.1111/eci.12319

TY - JOUR

T1 - Research update for articles published in EJCI in 2012

AU - Dullaart, R P.

AU - Al-Daghri, N.M.

AU - Ashina, M.

AU - Bouzas-Mosquera, A.

AU - Brunetti, N.D.

AU - Buechler, C.

AU - Chen, H.S.

AU - Corrales, J.J.

AU - D'Archivio, M.

AU - Cas, A.D.

AU - Pino, G.G.

AU - Gomez-Abril, S.A.

AU - Gyori, D.

AU - Haslacher, H.

AU - Herder, C.

AU - Kerstens, M.N.

AU - Koutsilieris, M.

AU - Lupattelli, G.

AU - Mocsai, A.

AU - Msaouel, P.

AU - Orfao, A.

AU - Ormazabal, P.

AU - Pacher, R.

AU - Perkmann, T.

AU - Peteiro, J.

AU - Plischcke, M.

AU - Reynaert, N.L.

AU - Ricci, M.A.

AU - Robles, N.R.

AU - Rocha, M.

AU - Rutten, E.P.

AU - Sabico, S.

AU - Santamaria, F.

AU - Santoro, F.

AU - Schmid, A.

AU - Schmidt, M.

AU - Schytz, H.W.

AU - Shyu, K.G.

AU - Tada, H.

AU - Thorand, B.

AU - Valerio, G.

AU - Vesely, D.L.

AU - Wu, T.E.

AU - Yamagishi, M.

AU - Yeh, Y.T.

PY - 2014/10

Y1 - 2014/10

N2 - Phospholipase Cgamma2 (PLCgamma2) is a critical regulator of osteoclast differentiation and basal bone resorption, which was demonstrated by Kertesz et al. in agreement with previous reports(1). The role of the PLCgamma isoenzyme in bone resorption and in adhesion receptor signalling of osteoclasts was further emphasized in a recent review(2) reinforcing the statements made by Kertesz et al.,(1). Moreover, Dr. Faccio's group provided genetic evidence that targeting PLCgamma2 can suppress inflammatory osteolysis(3). This article is protected by copyright. All rights reserved.

AB - Phospholipase Cgamma2 (PLCgamma2) is a critical regulator of osteoclast differentiation and basal bone resorption, which was demonstrated by Kertesz et al. in agreement with previous reports(1). The role of the PLCgamma isoenzyme in bone resorption and in adhesion receptor signalling of osteoclasts was further emphasized in a recent review(2) reinforcing the statements made by Kertesz et al.,(1). Moreover, Dr. Faccio's group provided genetic evidence that targeting PLCgamma2 can suppress inflammatory osteolysis(3). This article is protected by copyright. All rights reserved.

KW - CORONARY-ARTERY-DISEASE

KW - AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA

KW - NEAR-INFRARED SPECTROSCOPY

KW - LOW-FREQUENCY OSCILLATIONS

KW - ISCHEMIC-HEART-DISEASE

KW - SMOOTH-MUSCLE-CELLS

KW - OXIDATIVE STRESS

KW - METABOLIC SYNDROME

KW - ADIPOSE-TISSUE

KW - SOLUBLE CD163

U2 - 10.1111/eci.12319

DO - 10.1111/eci.12319

M3 - Article

SN - 0014-2972

VL - 44

SP - 1010

EP - 1023

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

IS - 10

ER -